OPENING A GLP-1 AND METABOLIC PROGRAM IN PHILADELPHIA: TWO STATE BOARDS AND A CITY TAX REGIMEPennsylvania splits physician regulation across two boards, certifies nurse practitioners through a third, and legislated on telemedicine in 2024. Philadelphia then adds a licensing and tax layer of its own. This page is general commentary, not legal advice.

Educational overview · Approx. 8 min read · illustrative, not advice

Pennsylvania splits physician regulation across two boards, certifies nurse practitioners through a third, and legislated on telemedicine in 2024. Philadelphia then adds a licensing and tax layer of its own. This page is general commentary, not legal advice.

Market size is real, and it is still not a claim about you

The category forecasts differ by definition, and the spread is instructive. Morgan Stanley Research projects global GLP-1 sales across diabetes and obesity at approximately 190 billion dollars by 2035, more than double 2025 levels. Goldman Sachs Research forecasts the global anti-obesity drug market at approximately 95 billion dollars by 2030, revised down from roughly 130 billion. Grand View Research projects the narrower GLP-1 weight-loss segment at approximately 48.8 billion dollars by 2030 on an 18.5 percent compound annual growth rate from 2025.

Those three numbers are not in conflict; they measure different boundaries around different time horizons. The useful discipline is to notice that the most credible mover in the set is downward: Goldman revising its own forecast down is worth more than any headline maximum.

None of it says anything about what a Philadelphia operator would collect, and Atlas will not build that bridge. Atlas has no franchise disclosure document, and income figures without one are both an FTC problem and a franchise-law problem. What follows is the Pennsylvania-specific structure instead, because that is the part you can actually control.

Question one: Pennsylvania runs two physician boards

Pennsylvania regulates allopathic physicians through the State Board of Medicine and osteopathic physicians through the State Board of Osteopathic Medicine, both under the Bureau of Professional and Occupational Affairs at the Department of State. Which board governs your medical director determines which rule set your clinical policies are drafted against.

Entity formation runs through the Department of State's corporations bureau, where professional corporations and restricted professional companies are filed. Ask counsel which entity form suits your structure and what the professional designation requires at filing and at renewal.

On ownership, assume nothing. The law firm Stevens and Lee, writing on Pennsylvania's corporate practice of medicine doctrine, discusses courts finding that management services arrangements created de facto partnerships with the practices they served. Ask your Pennsylvania counsel whether the structure you have in mind is consistent with how Pennsylvania treats lay control of a medical practice.

Question two: the CRNP collaborative agreement

Pennsylvania certifies nurse practitioners through the State Board of Nursing, and 49 Pa. Code section 21.285 requires a prescriptive authority collaborative agreement identifying the parties: the collaborating physician, the CRNP, and at least one substitute physician for when the collaborator is unavailable. The CRNP must notify the Board in writing when that agreement is updated or terminated.

Older material describes a numeric ceiling on how many CRNPs one physician may cover. Treat that as a question, not a fact: section 21.287, which formerly addressed physician supervision of prescribing CRNPs, appears as reserved in the current Subchapter C. Ask your Pennsylvania counsel whether any numeric limit applies to your arrangement, and confirm it with the State Board of Nursing before building a staffing model on any figure.

Whatever the answer, clinical capacity is a planning input rather than a compliance footnote, and it interacts with how the program enrolls and serves members. Functional medicine high-ticket enrollment is the piece that connects clinical capacity to how a program is actually sold without touching anyone's numbers.

Question three: Pennsylvania's late arrival to telemedicine legislation

Pennsylvania spent years without dedicated telemedicine legislation before Act 42 of 2024, signed on 3 July 2024, which amends the insurance title of the Pennsylvania Consolidated Statutes. Per the Department of State's telemedicine FAQs, policies with forms or rates filed on or after 31 March 2025 must cover certain services rendered through telemedicine. That is a coverage instrument; board practice standards are a different one. Ask counsel which of them your clinical protocols are drafted against.

On licensure the same FAQs are direct: practitioners wishing to serve individuals in Pennsylvania need Pennsylvania licensure, in person or through an electronic interaction. Serving members across the Delaware Valley into New Jersey or Delaware is a licensure question first, and one for counsel in each state. The Interstate Medical Licensure Compact covered up to 43 member states as of March 2026.

Ask Atlas to put this in writing: which state medical licenses the partner's separately licensed medical entity will hold at launch for a Philadelphia-based program serving the tri-state area

Question four: the Philadelphia layer, which is not optional and not small

Philadelphia operates its own business tax and licensing regime. Per the City of Philadelphia Department of Revenue, a business operating in the city generally needs a Commercial Activity License and is subject to the Business Income and Receipts Tax, which has both a receipts component and an income component, alongside city wage tax withholding for employees.

Confirm current rates, filing thresholds and registration steps with the Department of Revenue or your accountant. The point here is not the numbers, it is that the city layer exists, applies from the first day of operation, and is administered separately from anything at the state level.

A Philadelphia address therefore carries state entity filings, state professional licensing, city licensing and city tax registration. Sequence them in the build plan rather than discovering them in order of who sends a notice first.

Question five: license versus franchise, and why the answer changes what you own

If you are comparing this against a franchise offering, run the difference between a franchise and a license agreement before comparing anything else. The entry figure is the least informative number in a franchise disclosure document; the recurring obligations and the control terms are where the shape of the deal actually lives.

Atlas terms are deliberately short: a one-time license fee, zero percent of partner revenue, no ongoing partner fees, and no assigned exclusive geography. Franchises sell territory and then enforce it against you; Atlas does not sell geography at all. The fee is disclosed on the fit call rather than published. The license fee is one-time. It carries 0% of revenue and no ongoing partner fees. The figure is not published anywhere, by design — it is disclosed in full on the fit call, where it can be put next to what it covers instead of floating on its own.

For the wider read on where this category sits and why cash-pay demand is structural rather than faddish, the metabolic wellness market overview is the piece that frames it without a single earnings implication in it.

What Atlas builds for a Philadelphia partner

The license covers the telehealth stack, the ordering system, member AI coaching, the brand kit and the operational playbooks, delivered as one build. Atlas provides no medical services and employs no clinicians. Clinical care is delivered by a separately licensed medical entity you establish with your own counsel.

Your entity, your board relationships, your CRNP agreements, your city registrations and your compliance posture are permanently yours. That is the trade for owning the business outright rather than operating someone else's brand under revocable terms.

— only a named, consented Atlas partner quoted verbatim with written permission on file. No composite partners, no invented credentials, no stock portraits. When your counsel has answered the ownership, collaborative-agreement, licensure and city-registration questions, bring the answers to the apply page.

What this page is not

Atlas Metabolic is not a law firm. Everything above is general commentary for people evaluating a build, and none of it is legal advice or a legal opinion about your situation.

Regulation here changes, and it varies with the structure you choose: two arrangements at the same Philadelphia address can land differently. Treat this page as a snapshot of questions worth asking, never as a statement of what Pennsylvania requires or permits.

Every question above belongs to your own healthcare counsel licensed in Pennsylvania, confirmed with the boards and the city directly. Atlas provides no medical services and employs no clinicians; clinical care is delivered by a separately licensed medical entity.

FREQUENTLY ASKED QUESTIONS.